Lynparza 100mg Tablet

By Lynparza

Rx

8 Tablet in a Strip

Composition icon

Composition

Olaparib(100mg)

Manufacturer - AstraZeneca icon

Manufacturer - AstraZeneca

Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Expires on or after icon

Expires on or after

July, 2025

About Lynparza 100mg Tablet

Lynparza 100mg Tablet is prescribed for individuals with ovarian cancer and HER2-negative metastatic breast cancer. It is important to follow the dosage and duration guidelines provided by your doctor. This medication is specifically designed to target these types of cancer and is essential in the treatment process. Follow your healthcare provider's instructions carefully to ensure the most effective treatment outcome.


How to use the Lynparza 100mg Tablet

To use Lynparza 100mg Tablet correctly, it is essential to follow your doctor's instructions regarding the dosage and duration. Swallow the tablet whole with water and do not chew, crush, or break it. This medication should be taken as a whole to ensure its proper effects on your body. It is important to strictly adhere to the prescribed dose and duration to achieve the best results and minimize potential side effects. If you have any questions or concerns about how to use Lynparza, consult your doctor or healthcare provider for guidance and clarification.


What conditions Lynparza 100mg Tablet treats?

Lynparza 100mg Tablet is used to treat ovarian and HER2-negative metastatic breast cancer. It is important to follow your doctor's instructions on how to take this medicine. Some common side effects may include nausea, fatigue, anemia, vomiting, diarrhea, loss of appetite, headache, decreased blood cells, taste changes, cough, breathlessness, indigestion, and abdominal pain. These side effects usually improve as your body gets used to the medicine, but if they persist or cause concerns, consult your doctor for further guidance.


Should you consult a doctor?

If you experience side effects while taking Lynparza 100mg Tablet for ovarian or HER2-negative metastatic breast cancer, it's important to know when to seek medical attention. While most side effects may resolve as your body gets used to the medication, some may persist and require doctor consultation. Contact your healthcare provider if you have persistent nausea, fatigue, anemia, vomiting, diarrhea, loss of appetite, headache, decreased blood cell count, taste changes, cough, breathlessness, indigestion, or abdominal pain. Your doctor can assess your symptoms and provide guidance on managing any adverse effects. Always follow your doctor's recommended dosage and treatment duration for optimal results and safety.


Side effects of Lynparza 100mg Tablet

When taking Lynparza 100mg Tablet, some patients may experience side effects as their body gets used to the medication. These side effects may not need medical attention and often go away on their own. However, if they continue or if you are concerned, it is important to talk to your doctor. Common side effects of Lynparza 100mg Tablet include nausea, fatigue, anemia (low red blood cell count), vomiting, diarrhea, loss of appetite, headache, decreased blood cell counts (red cells, white cells, and platelets), taste changes, cough, breathlessness, indigestion, and abdominal pain. It is essential to report any persistent or severe side effects to your healthcare provider for proper management and guidance.


Safety advice

scroll

liver

Consult with your doctor for proper guidance before using Lynparza 100mg Tablet.

scroll

kidney

Consult with your doctor for proper guidance before using Lynparza 100mg Tablet.

scroll

alcohol

Consult your doctor when consuming alcohol with Lynparza 100mg Tablet.

scroll

driving

When taking Lynparza 100mg Tablet, it is uncertain if driving ability is affected. Avoid driving if you encounter symptoms that impact focus and reaction time.

scroll

pregnancy

Information about using Lynparza 100mg Tablet during pregnancy is not available. It is advisable to consult your doctor for guidance.

scroll

breastfeeding

It is better to consult your doctor before using Lynparza 100mg Tablet during breastfeeding.


Consumption warning before consuming Lynparza 100mg Tablet

Before consuming Lynparza 100mg Tablet, it is important to note that this medication is specifically prescribed for the treatment of ovarian and HER2-negative metastatic breast cancer. It is crucial to follow the dosage instructions provided by your doctor, both in terms of the amount of the medication to take and the duration for which it should be taken. It is imperative not to exceed the recommended dose or duration without consulting your healthcare provider. Additionally, it is advised to inform your doctor about any other medications or supplements you are currently taking to avoid any potential interactions. Adhering to these guidelines can help ensure the safe and effective use of Lynparza 100mg Tablet in the management of your condition.


Additional Information

Habit FormingNo
Chemical ClassPthalazinone derivatives
Therapeutic Class-
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

43328

Inclusive of all taxes

Content verified by

chevron-right

Dr. Monie Riju Simon

MBBS - General Medicine

Last update on 11-Feb-2025